Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...
Listen with Speechify 0:00 1:00 By Edyta Zielinska Please download the Adobe Flash Player to view this content: Diverting a Diet Drug The Good Fat The Future of the FDA The Trouble with Tech Transfer ...
As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback